BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184
384 results:

  • 1. Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinoma.
    Sakata T; Yoshio S; Yamazoe T; Mori T; Kakazu E; Aoki Y; Aoyanagi N; Okamoto T; Ito T; Toyoda H; Kawaguchi T; Ono Y; Takahashi Y; Taketomi A; Kanto T
    Front Immunol; 2024; 15():1389411. PubMed ID: 38638429
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Intratumoral cxcr4
    Lu Z; Wang X; Feng J; Chai W; Wang W; Wang Q; Yang S; Yang W; Su Y; Mou W; Peng Y; Wang H; Gui J
    Front Immunol; 2024; 15():1363454. PubMed ID: 38487536
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Granzyme B+ B cells detected by single-cell sequencing are associated with prognosis in patients with intrahepatic cholangiocarcinoma following liver transplantation.
    Zhu JQ; Zhu Y; Qi M; Zeng Y; Liu ZJ; Ding C; Zhang T; Li XL; Han DD; He Q
    Cancer Immunol Immunother; 2024 Feb; 73(3):58. PubMed ID: 38386050
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. C-X-C motif chemokine receptor 4 inhibition promotes the effect of plantamajoside in hepatocellular carcinoma.
    Sun J; Liu W; Fu H; Li Y; Huang J; Wang Y; Zhu L
    Arab J Gastroenterol; 2024 Feb; 25(1):28-36. PubMed ID: 38220479
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Weekend Effect on Clinical Outcomes of Acute Lower Gastrointestinal Bleeding: A Large Multicenter Cohort Study in Japan.
    Hayasaka J; Kikuchi D; Ishii N; Kobayashi K; Yamauchi A; Yamada A; Omori J; Ikeya T; Aoyama T; Tominaga N; Sato Y; Kishino T; Sawada T; Murata M; Takao A; Mizukami K; Kinjo K; Fujimori S; Uotani T; Fujita M; Sato H; Suzuki S; Narasaka T; Funabiki T; Kinjo Y; Mizuki A; Kiyotoki S; Mikami T; Gushima R; Fujii H; Fuyuno Y; Gunji N; Toya Y; Narimatsu K; Manabe N; Nagaike K; Kinjo T; Sumida Y; Funakoshi S; Kobayashi K; Matsuhashi T; Komaki Y; Miki K; Watanabe K; Odagiri H; Hoteya S; Kaise M; Nagata N
    Dig Dis; 2023; 41(6):890-899. PubMed ID: 37669627
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization.
    Pei W; Wei K; Wu Y; Qiu Q; Zhu H; Mao L; Shi X; Zhang S; Shi Y; Tao S; Mao H; Pang S; Wang J; Liu M; Wang W; Yang Q; Chen C
    Gene; 2023 Nov; 885():147692. PubMed ID: 37562585
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment.
    Zhang Y; Han X; Wang K; Liu D; Ding X; Hu Z; Wang J
    Int J Nanomedicine; 2023; 18():4329-4346. PubMed ID: 37545872
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
    Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art.
    Lu G; Wang X; Cheng M; Wang S; Ma K
    Biomed Pharmacother; 2023 Sep; 165():115132. PubMed ID: 37423169
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Potential role of human umbilical cord stem cells-derived exosomes as novel molecular inhibitors of hepatocellular carcinoma growth.
    ElBadre HM; El-Deek SEM; Ramadan HK; Elbadr MM; Sabry D; Ahmed NM; Ahmed AM; El-Mahdy RI
    Apoptosis; 2023 Oct; 28(9-10):1346-1356. PubMed ID: 37338718
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. cxcr4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12/cxcr4 signaling axis in preclinical breast cancer model.
    Gupta N; Mohan CD; Shanmugam MK; Jung YY; Chinnathambi A; Alharbi SA; Ashrafizadeh M; Mahale M; Bender A; Kumar AP; Putti TC; Rangappa KS; Zhang X; Ahn KS; Sethi G
    Environ Res; 2023 Sep; 232():116335. PubMed ID: 37290620
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on cxcr4-Targeted Molecular Imaging.
    Kosmala A; Seifert S; Schneid S; Dreher N; Higuchi T; Weich A; Serfling SE; Hartrampf PE; Einsele H; Buck AK; Topp MS; Duell J; Werner RA
    Mol Imaging Biol; 2023 Aug; 25(4):758-764. PubMed ID: 37286923
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. 68Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma: Comparison Between Changes in Lesion cxcr4 Expression on PET and Lesion Size and Diffusivity on MRI.
    Mayerhoefer ME; Raderer M; Weber M; Lamm W; Kiesewetter B; Hacker M; Nics L; Schmitl S; Leithner D; Wester HJ; Haug A
    Clin Nucl Med; 2023 Jul; 48(7):557-562. PubMed ID: 37272977
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment.
    Santagata S; Rea G; Castaldo D; Napolitano M; Capiluongo A; D'Alterio C; Trotta AM; Ieranò C; Portella L; Di Maro S; Tatangelo F; Albino V; Guarino R; Cutolo C; Izzo F; Scala S
    Hepatol Int; 2024 Apr; 18(2):568-581. PubMed ID: 37142825
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. In vivo validation of
    Renard I; Domarkas J; Poty S; Burke BP; Roberts DP; Goze C; Denat F; Cawthorne CJ; Archibald SJ
    Nucl Med Biol; 2023; 120-121():108335. PubMed ID: 37068392
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ScRNA-seq revealed targeting regulator of G protein signaling 1 to mediate regulatory T cells in Hepatocellular carcinoma.
    Zou L; Liu K; Shi Y; Li G; Li H; Zhao C
    Cancer Biomark; 2023; 36(4):299-311. PubMed ID: 36938729
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Role of Cytokines in the Metastasis of Solid Tumors to the Spine: Systematic Review.
    Łabędź W; Przybyla A; Zimna A; Dąbrowski M; Kubaszewski Ł
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835198
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Knockdown of CD44 inhibits proliferation, migration, and invasiveness in hepatocellular carcinoma cells by modulating cxcr4/Wnt/β-Catenin Axis.
    Song X; Ding F; Luo W; Tao J; Yang K; Li Q; Zhang Z
    Acta Biochim Pol; 2023 Feb; 70(1):117-122. PubMed ID: 36735564
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Loganic acid regulates the transition between epithelial and mesenchymal-like phenotypes by alleviating MnSOD expression in hepatocellular carcinoma cells.
    Kim NY; Ha IJ; Um JY; Kumar AP; Sethi G; Ahn KS
    Life Sci; 2023 Mar; 317():121458. PubMed ID: 36731649
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Sequential Treatment with Activin and Hepatocyte Growth Factor Induces FOXM1 to Promote Colorectal cancer liver Metastasis.
    Peng H; Ye T; Deng L; Yang X; Jiang Z; Guo J
    Can J Gastroenterol Hepatol; 2022; 2022():8996203. PubMed ID: 36591565
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 20.